Johnson & Johnson (JNJ)'s Method To Capturing Disruptive Innovation In Clinical Trials
7/7/2014 6:50:02 AM
In the pharmaceutical industry, gaps often exist between companies and internal working groups. Consider one of the industry’s largest players, Johnson & Johnson (NYSE: JNJ), which has more than 127,000 employees and operates more than 250 companies organized into several business segments in 60 countries.
J&J’s pharmaceutical segment consists of six Janssen pharmaceutical companies, including Janssen R&D, which contains the Janssen Healthcare Innovation (JHI) team. And while the R&D arm is focused on discovering and developing medicines for unmet medical needs, JHI’s vision is to help accelerate the transformation of J&J from a healthcare product company to simply a healthcare company.
Help employers find you! Check out all the jobs and post your resume.
comments powered by